Literature DB >> 30714450

L-carnitine does not ameliorate asparaginase-associated hepatotoxicity in a C57BL6 mouse model.

Yiwei Liu1, Laura J Janke2, Lie Li1, Mary V Relling1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30714450      PMCID： PMC6635003          DOI： 10.1080/10428194.2019.1571198

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  14 in total

1.  Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine.

Authors:  Gary Lu; Vinit Karur; Jon D Herrington; Mary G Walker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

2.  Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors.

Authors:  Chadi Al-Nawakil; Lise Willems; Cedric Mauprivez; Benjamin Laffy; Mona Benm'rad; Jerome Tamburini; Helene Fontaine; Philippe Sogni; Benoit Terris; Didier Bouscary; Laurence Moachon
Journal:  Leuk Lymphoma       Date:  2013-11-14

3.  Effect of L-carnitine treatment for valproate-induced hepatotoxicity.

Authors:  T P Bohan; E Helton; I McDonald; S König; S Gazitt; T Sugimoto; D Scheffner; L Cusmano; S Li; G Koch
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

4.  Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Authors:  Nina Toft; Henrik Birgens; Jonas Abrahamsson; Laimonas Griškevičius; Helene Hallböök; Mats Heyman; Tobias Wirenfeldt Klausen; Ólafur Gísli Jónsson; Katrin Palk; Kaie Pruunsild; Petter Quist-Paulsen; Goda Vaitkeviciene; Kim Vettenranta; Ann Asberg; Louise Rold Helt; Thomas Frandsen; Kjeld Schmiegelow
Journal:  Eur J Haematol       Date:  2015-04-24       Impact factor: 2.997

5.  Investigation of protective effect of L-carnitine on L-asparaginase-induced acute pancreatic injury in male Balb/c mice.

Authors:  Inan Kaya; Mehmet Citil; Mahmut Sozmen; Mahmut Karapehlivan; Gulsen Cigsar
Journal:  Dig Dis Sci       Date:  2014-12-14       Impact factor: 3.199

6.  Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: a randomized, clinical trial.

Authors:  Shima Hatamkhani; Hossein Khalili; Iman Karimzadeh; Simin Dashti-Khavidaki; Alireza Abdollahi; Sirous Jafari
Journal:  J Gastroenterol Hepatol       Date:  2014-05       Impact factor: 4.029

7.  L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity.

Authors:  Ruham Alshiekh-Nasany; Dan Douer
Journal:  Acta Haematol       Date:  2016-02-04       Impact factor: 2.195

8.  Asparaginase-Induced Hypertriglyceridemia Presenting as Pseudohyponatremia during Leukemia Treatment.

Authors:  Ashley Hinson; Dorothee Newbern; Corinne M Linardic
Journal:  Case Rep Pediatr       Date:  2014-10-27

9.  Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.

Authors:  B Patel; A A Kirkwood; A Dey; D I Marks; A K McMillan; T F Menne; L Micklewright; P Patrick; S Purnell; C J Rowntree; P Smith; A K Fielding
Journal:  Leukemia       Date:  2016-08-02       Impact factor: 11.528

10.  Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia.

Authors:  H Alachkar; N Fulton; B Sanford; G Malnassy; M Mutonga; R A Larson; C D Bloomfield; G Marcucci; Y Nakamura; W Stock
Journal:  Pharmacogenomics J       Date:  2016-03-29       Impact factor: 3.550
View more
  4 in total

Review 1.  Pharmacogenomics and ALL treatment: How to optimize therapy.

Authors:  Seth E Karol; Jun J Yang
Journal:  Semin Hematol       Date:  2020-10-20       Impact factor: 3.851

2.  Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in mice.

Authors:  Gundala Venkata Naveen Kumar; Keito Hoshitsuki; Sanjay Rathod; Manda J Ramsey; Lauren Kokai; Erin E Kershaw; Wen Xie; Christian A Fernandez
Journal:  Acta Pharm Sin B       Date:  2021-12-04       Impact factor: 11.413

3.  Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemia.

Authors:  Jessica L Sea; Etan Orgel; Ting Chen; Rebecca L Paszkiewicz; Abigail S Krall; Matthew J Oberley; Linsey Stiles; Steven D Mittelman
Journal:  Leuk Lymphoma       Date:  2019-09-16

4.  Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.

Authors:  Rachael Schulte; Ashley Hinson; Van Huynh; Erin H Breese; Joanna Pierro; Seth Rotz; Benjamin A Mixon; Jennifer L McNeer; Michael J Burke; Etan Orgel
Journal:  Cancer Med       Date:  2021-09-16       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.